Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166761 | SCV000217574 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000423579 | SCV000529748 | likely benign | not specified | 2016-07-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000546857 | SCV000660359 | likely benign | Fanconi anemia complementation group O | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166761 | SCV001358460 | likely benign | Hereditary cancer-predisposing syndrome | 2019-03-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000423579 | SCV002068095 | uncertain significance | not specified | 2020-04-10 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000166761 | SCV002531791 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-21 | criteria provided, single submitter | curation |